R
heumatic heart disease (RHD) remains a major public health concern, especially in low-and middle-income countries, where it is the leading cause of cardiovascular death in children and young adults. 1 Late presentation and late diagnosis of patients with RHD remains a key driver of high morbidity and mortality. 2 During the last decade, screening echocardiography to identify RHD (termed latent RHD) has emerged as a powerful tool for active case finding, epidemiology, and advocacy. [3] [4] [5] [6] [7] [8] [9] [10] Proponents of screening echocardiography have hope that diagnosis of latent RHD and early initiation of penicillin prophylaxis will prevent advancement to clinically significant disease, 11, 12 although this has not yet been proven.
Early in the development of screening echocardiography, it became clear that a standardized set of diagnostic criteria were needed to allow replication and comparison between sites. 13, 14 An international expert working group was convened by the World Heart Federation (WHF), and in 2012, the first evidence-based criteria were published. 15 These criteria take into consideration morphological and functional changes of the left heart valves and classify cases into the categories of normal, borderline RHD, or definite RHD. Prospective population-based screening utilizing the WHF criteria has shown high sensitivity for RHD, and high specificity has been inferred from studies showing low rates of RHD when applying the WHF criteria to low-risk populations. 10, 16 Now, just half a decade after publication, the WHF criteria have been widely adopted as the international gold standard for latent RHD diagnosis. Active case finding utilizing these criteria has occurred in >2 dozen populations, and >100 000 patients have been classified. [7] [8] [9] [10] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] Additionally, several cohorts of children initially diagnosed by these criteria have been followed longitudinally, providing a window into their outcomes. 6, [33] [34] [35] [36] [37] [38] [39] [40] As a result, the cumulative experience and evidence around early RHD diagnosis has grown immensely since publication of the WHF criteria, and a large amount of data are available from which the performance and weight of each feature might be tested. Analysis of these data holds promise for development of less complex criteria, focused specially on screening, which would allow echocardiography screening to be more reproducible and be applicable on a larger scale in endemic populations.
The aim of this study was to utilize 2012 WHF echocardiographic results from several large-scale screening studies to develop and validate a simplified score for RHD diagnosis and to determine whether this score was predictive of RHD progression.
METHODS

Study Design
The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results or replicating the procedure.
This study was designed to develop and validate a score for diagnosis of definite RHD and further to test whether the score would be able to predict disease progression. The study occurred in 3 phases (Figure 1 ) using data from established cohorts of asymptomatic children without history of acute rheumatic fever or RHD, who had undergone screening echocardiography. In all phases, expert consensus had been previously undertaken to determine echocardiographic classification (normal, borderline, and definite) and features according to the 2012 WHF criteria. 15 Retrospective search of 3 existing deidentified echocardiographic databases was used to gather basic demographic information (age and sex) and echocardiographic features at diagnosis. Each component of the 2012 WHF criteria was captured as present or absent, including each of the 4 individual criteria necessary for pathological aortic and mitral regurgitation. Studies were excluded from further analysis if they contained incomplete reporting of the WHF criteria or if the final diagnosis was congenital heart disease or other acquired heart disease. Further, in the derivation stage, echocardiograms classified as borderline RHD were also excluded to focus on the discriminating features of the extreme phenotypes-normal and definite RHD. Outcome was assessed in a cohort of latent RHD, defined as disease progression by echocardiogram.
The study was approved by the institutional review committee of both institutions, and written informed consent was obtained from all subjects.
Phase 1: Derivation
The derivation cohort included 12 056 echocardiograms of children screened through the PROVAR study (Programa de
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The World Heart Federation criteria are the current gold standard for the diagnosis of latent rheumatic heart disease (RHD). As data and experience using these criteria have grown, concerns related to the complexity of these criteria for RHD screening programs have been raised. In this regard, a refinement set of echocardiographic criteria for the diagnosis of RHD, focused specially on screening, would allow echocardiography screening to be more reproducible and be applicable on a larger scale in endemic populations. In the current study, a simplified score for latent RHD diagnosis, based on components of the World Heart Federation criteria, is highly accurate to recognize definite RHD. Furthermore, the new score provides the first tool for risk stratification at time of diagnosis of latent RHD, with potential value for clinical decision-making regarding secondary prophylaxis.
Rastreamento da Valvopatia Reumática) 41 -a large schoolbased screening program in Minas Gerais, Brazil.
In brief, the PROVAR study enrolled asymptomatic children aged 5 to 18 years without history of acute rheumatic fever or RHD. 9 Screening echocardiography was performed using standard portable (Vivid-Q; GE Healthcare, Milwaukee, WI) or handheld (VSCAN, GE Healthcare) echocardiography machines, and images were analyzed via telemedicine by cardiologists in Brazil and the United States. 9 For handheld studies in which spectral Doppler is not available, modified WHF criteria, based on the features of color regurgitant jet and morphological signs of RHD were used, as described previously.
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Phase 2: Validation
The validation cohort included 7312 echocardiograms of children screened in Gulu, Uganda. 21, 44 In brief, collaboration between the Uganda Heart Institute (Kampala, Uganda) and Children's National Health System undertook several schoolbased echocardiographic screening studies. 21, 44 Asymptomatic children without history of acute rheumatic fever/RHD underwent screening echocardiography using a standard portable echocardiography machine (Vivid-Q; GE Healthcare), and cardiologists with expertise in the 2012 WHF criteria analyzed the images. Because the WHF criteria include spectral Doppler assessment, handheld echocardiography equipment was not used in the validation cohort. Image acquisition settings using the highest fundamental imaging frequency of 3.6 MHz were standardized for standard portable echocardiography across all cohorts in this study.
Phase 3: Outcomes Prediction
The ability of this score to predict outcome was tested in an established and previously reported 40 longitudinal echocardiographic cohort, derived from 227 children (aged 5-18 years), identified with latent borderline or definite RHD and enrolled in the Ugandan National RHD Registry. Median length of echocardiographic follow-up in this cohort was 2.3 years (interquartile range, 2.0-2.9). Retrospective search of this database captured baseline diagnosis and presence or absence of score components. Previously determined outcomes were captured, including progression, stabilization, or regression. Unfavorable outcome or disease progression was defined as worsening in diagnostic category (borderline to definite), a worsening in the grade of mitral or aortic valve regurgitation, development or worsening of grade of mitral stenosis, or death because of complication of RHD. Regression was defined as an improvement in diagnostic category or an improvement in severity of mitral or aortic regurgitation based on the findings of the last available echocardiogram. Cases that did not meet these definitions for progression or regression were considered stable. In case of a nonlinear outcome, such as initial worsening and then return to baseline, the findings of the last available echocardiogram were considered as the final outcome.
Statistical Analysis
Statistical analysis was performed using the Statistical Package for Social Sciences for Windows, version 22.0 (SPSS, Inc, Chicago, IL), and R for Statistical Computing, version 2.15.1 (R Foundation, Vienna, Austria). Categorical variables were compared by χ 2 test, and continuous data were compared using Student unpaired t test when appropriate.
Logistic regression was used to identify the WHF component variables associated with definite RHD. The variables found to be significant at the level P <0.05 in univariate analysis were initially selected for a multivariable logistic regression analysis. To investigate the potential effect of multicollinearity among the WHF variables, changes in the regression coefficient estimates, in their corresponding standard errors, and in the variance inflation factor were examined. 45 The final model was then derived by including only relevant variables associated with definite RHD. A point-based scoring system was developed from the final multivariable logistic regression model. Points were assigned to each component by rounding the β-coefficient to the nearest integer, 46 and the score corresponded to the sum of the points, ranging from 0 to 21. Three risk groups (low, intermediate, and high) were defined based on predicted probabilities from logistic regression. A low-risk score was set as a predicted probability of RHD diagnosis of <2%, whereas high-risk score was set as a predicted risk of >40%, and intermediate risk in the middle range.
To assess the predictive accuracy of the scoring system for diagnosis of definite RHD, discrimination and calibration were evaluated using the area under the receiver operating characteristic curves and the Hosmer-Lemeshow test, respectively. 47 Additionally, the derivation cohort was randomly split into 2 separate groups as training (80%) and test (20%) samples, and the discrimination and calibration was evaluated by applying this fitted model to the test group. Cross-validation was repeated 1000× to generate an average, overall optimism-adjusted estimate of the C statistic. [48] [49] [50] The optimism in the model performance was estimated using bootstrapping techniques. 50 For external validation, the score was applied to an independent cohort to assess discrimination and calibration of the score model for definite RHD diagnosis.
The score was also applied to an independent population of children with latent RHD to assess its discrimination and calibration in predicting disease progression using logistic regression. The value of the score in predicting unfavorable outcome was assessed as a time-dependent variable in the Cox proportional hazards model. RHD progression-free survival rates of the 3 risk categories were estimated by the KaplanMeier method and compared by the log-rank test.
Additionally, clinical variables that may influence disease progression, specifically age and penicillin use, were included in the multivariable Cox regression model.
RESULTS
Derivation Cohort
Of the 12 056 echocardiograms in the derivation cohort, 2028 were excluded for incomplete reporting of the WHF criteria, 67 were excluded as other structural heart disease (mainly congenital and nonrheumatic abnormalities, especially mitral valve prolapse), and 460 were excluded because of classification as borderline RHD. Of the remaining 9501 echocardiographic studies, 58 (0.6%) were classified as definite RHD and 9443 (99.4%) as normal. Table 1 contains demographics and baseline echocardiographic features of this cohort (including borderline RHD for comparison of component diagnoses). Of note, the cohort did not contain any patients with mitral stenosis or the component aortic valve prolapse.
At univariate analysis, the WHF parameters associated with definite RHD were identified ( Table 2 ). All morphological criteria for mitral valve and 2 morphological criteria (focal valve thickening and coaptation defect) for aortic valve involvement were initially selected. Restricted leaflet motion of aortic valve occurred in only 3 children who had definite RHD. All 4 variables of pathological regurgitation in both valves were also associated with RHD diagnosis.
Subsequently, to avoid multicollinearity by including all statistically significant variables with redundant information, we selected only the most relevant variable for pathological regurgitation: length of mitral regurgitation (≥2 cm) and aortic (any) regurgitation. Presence of regurgitation in multiple views, spectral Doppler assessment, and regurgitant velocity were considered redundant and did not enter together in the multivariable model. Although leaflet thickening and jet length were also collected as continuous variables, we included in the model as categorical variables, following the WHF criteria.
For the morphological criteria of the mitral valve, we included the 2 most frequent changes: anterior leaflet thickening (86%) and excessive leaflet tip motion (52%). For the aortic valve, as coaptation defect causes valvular regurgitation, only aortic regurgitation entered into the multivariable model. Focal aortic valve thickening was the morphological variable selected for the multivariable analysis.
Therefore, the final multivariable logistic regression model consisted of 5 variables: anterior leaflet thickening, excessive leaflet tip motion, regurgitation jet length ≥2 cm for mitral valve, and focal thickening and any regurgitation for aortic valve. These variables were then included in the development of the scoring system, resulting in a total score of 0 to 21 points (Table 3) . Three risk categories were defined for the diagnosis of definite RHD by estimating predicted probabilities from logistic regression (Figure 2 ). According to the predicted probability, low-risk scores were 0 to 6, intermediaterisk scores were 7 to 9, and high-risk scores were ≥10. Echocardiographic images of low, intermediate, and high risk are shown in Figure 3 (Movies I through III in the Data Supplement).
Bootstrap resampling showed negligible model optimism. The model validated in the test group showed a C statistic of 0.9982 (0.9967-0.9998) and well calibrated with a χ 2 of 7.4698 of Hosmer-Lemeshow, P=0.1879. Cross-validation with replication showed optimal discrimination of the model with an average of C statistic of 0.9984 (95% CI, 0.9958-0.9997). Subsequently, the model was applied to the subgroup of borderline to stratify them into risk categories. Of 460 children in borderline RHD category, 322 were reclassified in low risk with this score, 20 in high risk, and 118 remained as intermediate risk.
As the use of handheld echocardiography equipment could be a confounding factor, the performance of the score was tested according to the equipment used for screening in the derivation cohort (VSCAN, 5838 and Vivid-Q, 4123). There were no differences between the models related to the equipment used (P=0.222).
External Validation
Complete WHF data were available for all 7312 echocardiograms included in the validation cohort. Fiftytwo children were classified as definite RHD (0.7%), 254 as borderline (3.5%), and 7006 (95.8%) as normal. The characteristics of the validation cohort comparing with derivation cohort are shown in Table 4 . Children from the validation cohort were younger with less valve regurgitation but with similar prevalence of definite RHD.
The score was then applied to the validation cohort, and 7167 children were classified in the low-risk, 89 in the intermediate-risk, and 56 in the high-risk group. The estimated probability of definite RHD in the low-, intermediate-, and high-risk groups was <1%, 15.7%, and >57%, respectively. The model showed an optimal calibration and discrimination with a C statistic of 0.9949 (95% CI, 0.9933-0.9965) with a χ 2 of 11.652 of Hosmer-Lemeshow; P=0.1132.
Of note, of 7006 children classified as normal by the standard WHF criteria, 6998 were reclassified into lowrisk, 6 in intermediate-risk, and 2 in high-risk category.
Outcomes Prediction
Clinical and echocardiographic characteristics of the derivation cohort as compared with the 227 children in the outcomes cohort are shown in Table 5 . At diagnosis, 164 (72.2%) were classified as borderline and 63 (27.7%) as definite RHD. The proportion of borderline RHD at diagnosis was greater in the derivation cohort. Although focal thickening of aortic valve leaflets was more frequent in Uganda than in Brazil (6% versus 2%; P=0.014), the other morphological features of RHD and valvular regurgitation were similar between the 2 populations. The original score model was then applied to this external population with latent RHD. The model showed good discrimination and calibration with a C statistic of 0.811 for predicting disease progression (95% CI, 0.720-0.902).
A low-risk score had a predicted probability of progression of ≤5.6%; medium risk ranging from 8.3% to 17.5%, and high risk of ≥24.6%. The probability of unfavorable outcome according to the total score is shown in Figure 4 . Based on the score in this latent Applying the score to predict disease outcomes, 6 of 140 (4.3%) in the low-risk group showed disease progression, whereas 75 (53.6%) had regression over time. Similarly, of the 31 classified as high risk, only 3 (9.7%) regressed and 28 (90.3%) either progressed or remained stable (with an abnormal echocardiogram) during short-term follow-up. RHD status during the follow-up in the external validation cohort according to risk categories is shown in Figure 5 .
Considering 164 children who were classified as borderline RHD at the time of the first screening echocardiography, the score reclassified 127 in lowrisk, 27 in intermediate-risk, and 10 in high-risk categories. Of those children in low risk, 122 (96.1%) showed regression, whereas 6 of 10 (60%) high-risk children had disease progression (P<0.001). Among the borderline cases classified in intermediate risk, 81.5% remained stable or showed regression over time. Figure 6 compares the predicted-to-observed adverse outcome for each risk score group in the population with latent RHD.
Progression-free survival rates in low-risk children at 1, 2, and 3 years of follow-up were 100%, 100%, and 93%, respectively, compared with 98%, 93%, and 70% in the intermediate group and 90%, 60%, and 47% in the high-risk group (Figure 7) . The point-based score in continuous format was associated with disease progression, with the risk increased for every 1-point incremental in the score (hazard ratio, 1.270; 95% CI, 1.188-1.358; P<0.001). Considering the low risk as a reference category, the hazard ratio for unfavorable out- RHD indicates rheumatic heart disease. *A simplified RHD screening protocol used mitral regurgitation ≥1.5 cm or the presence of any aortic regurgitation to define screen positive for RHD.
†A simplified criterion. Reference approach aortic valve regurgitation, ≥1 cm. age and score was not predictor of disease progression (P=0.869).
DISCUSSION
The publication and widespread adoption of the 2012 WHF criteria 15 was a major advancement in the diagnosis of latent RHD, providing the best evidence available at the time on the key features. Now, more than half a decade later, large datasets utilizing these criteria offer the opportunity to test the performance and weight of its individual components, and for the first time, robust longitudinal data exist to assess outcomes prediction. In the current study, we have established a simplified combination of WHF components with nearly perfect performance to discriminate definite RHD from normal. Further, we translated this simplified model into an RHD risk score, which provided an accurate prediction of RHD outcome in both borderline and definite latent RHD in an established longitudinal cohort.
In our analysis, we were able to demonstrate nearperfect discrimination between normal and definite RHD using only 5 components. This simplified diagnostic model addresses one of the major critiques of the WHF criteria-their complexity. 51 The WHF criteria were intended for RHD diagnosis 14, 15, [52] [53] [54] ; the ease and practicality of using them in screening environments, where most latent RHD is detected, and by nonexpert providers, who serve as the primary workforce in many RHD-endemic areas, has been questioned. *Data are expressed as number (percentage) or as a mean±SD. †Type of machine: in the derivation cohort, VSCAN was used in 5838 and Vivid-Q in 4123 of the children, whereas in validation cohort, only Vivid-Q was used.
‡Comparison between derivation and validation cohorts. Simplified screening protocols have been proposed, all excluding morphological criteria and simplifying the functional criteria by only measuring regurgitation jet length. 10, 13, 22, 43, 44 Although this approach is practical, it misses isolated morphological abnormalities that can occur in the absence of pathological regurgitation early in RHD. 13 Additionally, full application of the 2012 WHF criteria requires an echocardiogram with spectral Doppler, only currently available on fully functional portable echocardiography machines. The 5 components included in our model (mitral regurgitation ≥2 cm, thickening of the anterior mitral valve leaflet, excessive motion of the anterior mitral leaflet, any aortic regurgitation, and focal thickening of the aortic valve) can be assessed by handheld echocardiography equipment, which is substantially less expensive, consequently more available, and has shown to have good accuracy for latent RHD detection. 21, 22 Eliminating the need for spectral Doppler also opens the door for 1-stage screening (without confirmatory follow-up) for diagnosis, which could reduce costs and improve the practicality of active RHD case finding.
A refinement set of echocardiographic criteria for the diagnosis of RHD is fundamental in the context of global screening efforts. Our findings of simplified criteria may improve the practicality and affordability of echocardiographic screening programs, particularly using handheld echocardiography devices by nonexperts in resource-limited environments. Our study overcomes a major barrier for implementation of echocardiographybased screening with potential to incorporate this strategy for active surveillance of RHD in endemic areas.
Another major barrier in echocardiographic screening for RHD remains the lack of data on prognosis after case detection. 51 Follow-up of children diagnosed with latent RHD has shown that ≈40% of children with borderline and definite RHD will show disease improvement, often reverting to normal, over a period of only 1 to 2 years irrespective of penicillin prophylaxis. 40 Currently, other than severity of valvular dysfunction at diagnosis, 11 there are no reliable markers to predict individual risk.
This concern is even more pronounced in children classified as having borderline RHD, as there is almost certainly some degree of overlap with normal findings and the reliability of the diagnosis has been debated. 14, 17, 36, 55, 56 Although many children do well, longitudinal data have also shown that a diagnosis of borderline RHD does confer increased risk of acute rheumatic fever and of adverse cardiac events. 36 The present study has several implications, not only on epidemiological aspects of the disease but also on the direct approach of the children and their families. Although there is no randomized trial, the decision to initiate secondary prophylaxis at diagnosis would be based on the risk of disease progression, which we believe is the major contribution of our study to the current state of knowledge of RHD.
This RHD risk score developed in this study provides the first tool for risk stratification at time of diagnosis of latent RHD. Through a retrospective analysis of large screening databases, the score was able to stratify risk in children with both borderline RHD and definite RHD, with children in the highest risk category showing significantly more progression over only 2 to 3 years.
Additionally, the more accurate prediction of disease progression may also improve the cost-effectiveness of population screening. Indeed, the prevalence of RHD relies on echocardiographic criteria because subclinical disease is 7 to 8× higher than that of clinically manifest disease, which is characterized by the presence of symptoms related to valvular dysfunction, mainly heart failure or embolic events or pathological valvular heart murmur detected during auscultation.
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Limitations
Our study has some limitations. First, this study has an inherent particularity, which is the lack of gold standard diagnostic test for RHD. However, a model based on a simplified set of criteria derived differently from WHF criteria was our strategy of dealing with the lack of a gold standard. Additionally, to overcome this limitation, the set of criteria was applied to an independent longitudinal cohort with latent RHD and showed an accurate prediction of disease outcome, which is the key finding of the study.
Second, model and score development was undertaken retrospectively, utilizing existing cohorts. Features of latent RHD differ between populations, and our derivation cohort did not have any cases of mitral stenosis or aortic valve prolapse. However, these more severe phenotypic presentations do not occur in isolation, typically being found with other features, restrictive motion of the mitral and aortic regurgitation, as examples. Our validation cohort did contain patients with these features, and discrimination between definite RHD and normal remained nearly perfect. Additionally, mitral stenosis is a late finding in RHD, and while undiagnosed Progression-free survival was significantly different among the 3 different risk groups (P <0.001 for each). The 3-y progression-free survivals were 93%, 70%, and 47% in the low-, intermediate-, and high-risk groups, respectively. children with mitral stenosis are detected through screening, particularly in the lowest resource environments, the high risk of adverse outcomes in these children is well established. 35, 40 Score performance was accurate in younger patients earlier in the course of their disease but needs to be tested in other populations. However, the use of data from both Brazil and Uganda increases the chances of reproducibility.
Third, the natural history of RHD varies according to environmental exposure to streptococcal infections, genetics, age at diagnosis, and other incompletely understood factors. Additionally, disease progression was defined based on longitudinal echocardiograms that were reinterpreted in series, as it is the standard method in clinical practice to determine an individual's outcome. However, there is a level of uncertainty around the definition of disease progression or improvement using echocardiographic definitions, especially related to measurement variability of morphological rheumatic features. Moreover, clinical disease progression, which includes development of heart failure, the need for valve intervention, and RHD-related complications, was not assessed in this study. The definitive validation of this echocardiographic score will require prospective longitudinal studies in diverse populations.
Conclusions
We developed an accurate simple score for latent RHD diagnosis based on the most commonly seen component diagnoses in the 2012 WHF criteria. This score is highly accurate to recognize definite RHD and provides the first tool for risk stratification, assigning children to low, intermediate, or high risk based on echocardiographic features at diagnosis. In retrospective application, the score performed well for prediction of adverse outcomes. This new tool needs further validation but has high potential value for improving the triage of children identified with latent RHD, in explaining individual risk to the child and family, and for influencing the decision to initiate or defer secondary prophylaxis. 
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